HealthEquity FY2026 net income more than doubled to USD 215.2 million as revenue rose 9% to USD 1.31 billion

Reuters03-18

<a href="https://laohu8.com/S/HQY">HealthEquity</a> FY2026 net income more than doubled to USD 215.2 million as revenue rose 9% to USD 1.31 billion

HealthEquity published an earnings release reporting fiscal Q4 revenue of USD 334.6 million, up 7%, and net income of USD 49.7 million, up 89%. Fiscal Q4 adjusted EBITDA was USD 132.9 million, up 23%, with adjusted EBITDA margin of 40% versus 35% a year earlier. For fiscal 2026, revenue rose 9% to USD 1.31 billion and net income more than doubled to USD 215.2 million. Total HSA assets grew 14% to USD 36.5 billion, and the company returned USD 301.7 million to shareholders through stock repurchases. For fiscal 2027, HealthEquity forecast revenue of USD 1.41 billion to USD 1.42 billion and adjusted EBITDA of USD 618 million to USD 628 million, with CEO Scott Cutler citing record new HSAs from sales and margin expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthEquity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603171601PRIMZONEFULLFEED9673688) on March 17, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2620408358?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 04:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620408358","market":"fut","top_or_hot":-1,"title":"HealthEquity FY2026 net income more than doubled to USD 215.2 million as revenue rose 9% to USD 1.31 billion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/HQY\">HealthEquity</a> FY2026 net income more than doubled to USD 215.2 million as revenue rose 9% to USD 1.31 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        HealthEquity published an earnings release reporting fiscal Q4 revenue of USD 334.6 million, up 7%, and net income of USD 49.7 million, up 89%. Fiscal Q4 adjusted EBITDA was USD 132.9 million, up 23%, with adjusted EBITDA margin of 40% versus 35% a year earlier. For fiscal 2026, revenue rose 9% to USD 1.31 billion and net income more than doubled to USD 215.2 million. Total HSA assets grew 14% to USD 36.5 billion, and the company returned USD 301.7 million to shareholders through stock repurchases. For fiscal 2027, HealthEquity forecast revenue of USD 1.41 billion to USD 1.42 billion and adjusted EBITDA of USD 618 million to USD 628 million, with CEO Scott Cutler citing record new HSAs from sales and margin expansion.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthEquity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603171601PRIMZONEFULLFEED9673688) on March 17, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HealthEquity FY2026 net income more than doubled to USD 215.2 million as revenue rose 9% to USD 1.31 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthEquity FY2026 net income more than doubled to USD 215.2 million as revenue rose 9% to USD 1.31 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-18 04:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/HQY\">HealthEquity</a> FY2026 net income more than doubled to USD 215.2 million as revenue rose 9% to USD 1.31 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        HealthEquity published an earnings release reporting fiscal Q4 revenue of USD 334.6 million, up 7%, and net income of USD 49.7 million, up 89%. Fiscal Q4 adjusted EBITDA was USD 132.9 million, up 23%, with adjusted EBITDA margin of 40% versus 35% a year earlier. For fiscal 2026, revenue rose 9% to USD 1.31 billion and net income more than doubled to USD 215.2 million. Total HSA assets grew 14% to USD 36.5 billion, and the company returned USD 301.7 million to shareholders through stock repurchases. For fiscal 2027, HealthEquity forecast revenue of USD 1.41 billion to USD 1.42 billion and adjusted EBITDA of USD 618 million to USD 628 million, with CEO Scott Cutler citing record new HSAs from sales and margin expansion.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthEquity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603171601PRIMZONEFULLFEED9673688) on March 17, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2210149790.SGD","symbol_name":"Natixis Thematics Subscription Economy R/A SGD-H","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL5pk2CW:1","article_id":"2620408358","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620408358","pubTimestamp":1773777817,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"HealthEquity published an earnings release reporting fiscal Q4 revenue of USD 334.6 million, up 7%, and net income of USD 49.7 million, up 89%. Fiscal Q4 adjusted EBITDA was USD 132.9 million, up 23%, with adjusted EBITDA margin of 40% versus 35% a year earlier. For fiscal 2026, revenue rose 9% to USD 1.31 billion and net income more than doubled to USD 215.2 million. Total HSA assets grew 14% to USD 36.5 billion, and the company returned USD 301.7 million to shareholders through stock repurchases. For fiscal 2027, HealthEquity forecast revenue of USD 1.41 billion to USD 1.42 billion and adjusted EBITDA of USD 618 million to USD 628 million, with CEO Scott Cutler citing record new HSAs from sales and margin expansion.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","BK4588":"碎股","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","BK4112":"金融交易所和数据","BK4154":"管理型保健护理","HQY":"HealthEquity","NDAQ":"纳斯达克OMX交易所","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","IE00BN0W2W23.USD":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (USD) ACC","IE00BN0W2V16.EUR":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (EUR) ACC","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","BK4585":"ETF&股票定投概念","IE00BN0W2T93.GBP":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (GBP) ACC","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD"},"translate_title":"HealthEquity 2026财年净利润增长一倍多，达到2.152亿美元，收入增长9%，达到13.1亿美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9,"HQY":0.9},"content_text":"HealthEquity FY2026 net income more than doubled to USD 215.2 million as revenue rose 9% to USD 1.31 billion\n    \n\n        HealthEquity published an earnings release reporting fiscal Q4 revenue of USD 334.6 million, up 7%, and net income of USD 49.7 million, up 89%. Fiscal Q4 adjusted EBITDA was USD 132.9 million, up 23%, with adjusted EBITDA margin of 40% versus 35% a year earlier. For fiscal 2026, revenue rose 9% to USD 1.31 billion and net income more than doubled to USD 215.2 million. Total HSA assets grew 14% to USD 36.5 billion, and the company returned USD 301.7 million to shareholders through stock repurchases. For fiscal 2027, HealthEquity forecast revenue of USD 1.41 billion to USD 1.42 billion and adjusted EBITDA of USD 618 million to USD 628 million, with CEO Scott Cutler citing record new HSAs from sales and margin expansion.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthEquity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603171601PRIMZONEFULLFEED9673688) on March 17, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2620408358","isCrawlerRequest":true}